Tscan Therapeutics Correlations

TCRX Stock

USD 1.81 0.03 1.63%

The current 90-days correlation between Tscan Therapeutics and Zura Bio Limited is 0.65 (i.e., Poor diversification). The correlation of Tscan Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Tscan Therapeutics Correlation With Market

Average diversification

The correlation between Tscan Therapeutics and DJI is 0.18 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Tscan Therapeutics and DJI in the same portfolio, assuming nothing else is changed.

Build AI portfolio with Tscan Stock

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Tscan Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

For more information on how to buy Tscan Stock please use our How to Invest in Tscan Therapeutics guide.

Moving together with Tscan Stock

0.61	ENTA	Enanta Pharmaceuticals	Pair Corr
0.73	HCM	HUTCHMED DRC	Pair Corr
0.77	ONC	BeiGene, Symbol Change	Pair Corr
0.66	IMVT	Immunovant	Pair Corr
0.66	JNJ	Johnson Johnson Earnings Call This Week	Pair Corr

Related Correlations Analysis

	ZURA	ANNX	INAB	WVE	ELEV	ERAS	HOWL	DRMA
ZURA		-0.13	0.37	0.62	0.35	0.44	-0.34	0.29	ZURA
ANNX	-0.13		-0.83	0.55	0.54	0.65	0.75	-0.65	ANNX
INAB	0.37	-0.83		-0.27	-0.45	-0.29	-0.59	0.7	INAB
WVE	0.62	0.55	-0.27		0.59	0.78	0.28	-0.12	WVE
ELEV	0.35	0.54	-0.45	0.59		0.5	0.33	-0.5	ELEV
ERAS	0.44	0.65	-0.29	0.78	0.5		0.49	-0.21	ERAS
HOWL	-0.34	0.75	-0.59	0.28	0.33	0.49		-0.48	HOWL
DRMA	0.29	-0.65	0.7	-0.12	-0.5	-0.21	-0.48		DRMA
	ZURA	ANNX	INAB	WVE	ELEV	ERAS	HOWL	DRMA

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

ERAS	+ 0.78	WVE
HOWL	+ 0.75	ANNX
DRMA	+ 0.7	INAB
ERAS	+ 0.65	ANNX
WVE	+ 0.62	ZURA
ELEV	+ 0.59	WVE

High negative correlations

INAB	- 0.83	ANNX
DRMA	- 0.65	ANNX
HOWL	- 0.59	INAB
DRMA	- 0.5	ELEV
DRMA	- 0.48	HOWL
ELEV	- 0.45	INAB

Risk-Adjusted Indicators

There is a big difference between Tscan Stock performing well and Tscan Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Tscan Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
ZURA	4.00	0.09	0.02	0.33	4.27	(5.42)	10.28	(7.50)	26.66
ANNX	4.03	0.73	0.11	2.00	4.42	(4.29)	10.63	(7.86)	23.91
INAB	4.07	(1.00)	0.00	(1.13)	0.00	0.00	7.75	(9.46)	41.97
WVE	3.27	0.14	0.05	0.32	4.72	(3.20)	7.19	(7.01)	26.72
ELEV	4.08	0.63	0.11	1.18	3.72	(6.18)	13.04	(7.69)	29.95
ERAS	4.60	0.03	0.04	0.25	5.46	(5.37)	13.01	(10.83)	40.51
HOWL	5.17	0.62	0.17	0.50	4.56	(6.48)	13.33	(8.05)	35.53
DRMA	3.21	(0.31)	0.00	(0.82)	0.00	0.00	8.47	(6.90)	22.00

Tscan Therapeutics Corporate Management

Justin McCue	Chief Officer	Profile
Leiden MBA	Principal Treasurer	Profile
Stephen Camiolo	Senior Access	Profile
Ray Lockard	VP Quality	Profile
Ray MBA	Senior Quality	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2025 Macroaxis LLC